NCT00214435View on ClinicalTrials.gov

Once Daily 3TC, Efavirenz and ddI for HIV Infection

PHASE4UnknownINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

May 31, 2004

Conditions

HIV InfectionAIDS

Interventions

DRUG

once daily minimum 3-drug regimen of anti-retroviral medications

Trial Locations (1)

2010

RECRUITING

407 Doctors, Sydney

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

407 Doctors

OTHER